Nabriva Therapeutics plc Total Assets
Nabriva Therapeutics plc had Total Assets of $10.58 million as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2023-10-19
- 2023-06-30: Assets $10.58M.
- 2023-03-31: Assets $24.34M.
- 2022-12-31: Assets $31.77M.
- 2022-09-30: Assets $48.24M.
| Period end | Assets |
|---|---|
| 2023-06-30 | $10.58M 10-Q · filed 2023-10-19 |
| 2023-03-31 | $24.34M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $31.77M 10-Q · filed 2023-10-19 |
| 2022-09-30 | $48.24M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $54.89M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $65.78M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $80.91M 10-K · filed 2023-04-17 |
| 2021-09-30 | $89.12M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $95.41M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $79.41M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $58.44M 10-K · filed 2022-03-29 |
| 2020-09-30 | $56.77M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $65.05M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $41.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $94.11M 10-K · filed 2021-03-11 |
| 2019-09-30 | $90.12M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $83.64M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $103.99M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $110.42M 10-K · filed 2020-03-12 |
| 2018-09-30 | $112.44M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $86.79M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $100.46M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $95.76M 10-K · filed 2019-03-12 |
| 2017-09-30 | $119.90M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $67.37M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $78.95M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $93.24M 10-K · filed 2018-03-16 |
| 2015-12-31 | $117.71M 10-K · filed 2017-03-24 |